Phase I clinical and pharmacokinetic study of taxol.
- Journal
- PubMed
In The Last Decade
doi.org/w27625162 →Countries where authors are citing Phase I clinical and pharmacokinetic study of taxol.
This map shows the geographic impact of Phase I clinical and pharmacokinetic study of taxol.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phase I clinical and pharmacokinetic study of taxol. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phase I clinical and pharmacokinetic study of taxol. more than expected).
Fields of papers citing Phase I clinical and pharmacokinetic study of taxol.
This network shows the impact of Phase I clinical and pharmacokinetic study of taxol.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Phase I clinical and pharmacokinetic study of taxol..
About Phase I clinical and pharmacokinetic study of taxol.
This paper, published in 1987, received 380 indexed citations . Written by Peter H. Wiernik, Edward L. Schwartz, J Strauman, Janice P. Dutcher, Richard B. Lipton and Elisabeth Paietta covering the research area of Oncology and Dermatology. It is primarily cited by scholars working on Oncology (285 citations), Molecular Biology (74 citations) and Dermatology (68 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w27625162.